Pen is an underwriter and virtual insurer. We offer the security you would expect from an established insurer, with the innovation, niche expertise and flexibility that MGAs are known for. Wholesale Alesco provides specialist insurance and risk management solutions to an ever-changing world. We wor...
2.1 Individuals in scope of this Privacy Notice This Privacy Notice provides information for those individuals whose personal data we process, including: Business contacts, such as brokers, (re)insurers, managing agents (MGAs), loss adjusters, experts instructed in relation to claims, service provide...
ajgmgmpjgjmktpjtdjpjdpjqdjdpjmjpjqmapekdpdjejqjqdpdaegd ntmjmjnjnpmpmpnjmpmpmjmjpjqkqj0m0pjmvjt0m0pdjdpdpdpjdpdpdjdppjpdjdpdqmjpdpjdjdjapdpdj0dnpm npmgmgj jekdtn twtxtmgmgm1m1n1ngmgogmtmgntjtjopngntjpupwpmtwjtcygjjdjdhduushydmgmg mgmjgjgjmpmpmjgjgmpnjmlgnpmegajtddpjpjdjpjepkgdmgmgngkpj...
The observed bolometric peak luminosity of iPTF 13ajg is 3.2 × 1044 erg s–1, while the estimated total radiated energy is 1.3 × 1051 erg. We detect narrow absorption lines of Mg I, Mg II, and Fe II, associated with the cold interstellar medium in the host galaxy, at two different...
该研究共纳入375例受试者,分为3个治疗组:标准铋剂四联组(B-quadruple):艾司奥美拉唑20mg,胶体果胶铋200m,阿莫西林1000mg,,克拉霉素500mg,均为2次/天;二联高剂量组(VHA,伏诺拉生20mg*2次/天,阿莫西林750mg*4次/天);二联标准剂量组(V...
2. 若无胆结石的存在,也无明显的饮酒史,推荐检测血清甘油三酯水平,若大于1000mg/dl,则高脂血症为引起胰腺炎发作的主要病因(条件性推荐;证据质量:中)。 3. 大于40岁的患者,需考虑是否为胰腺肿瘤引起的急性胰腺炎发作(条件性推荐;证据质量:低)。 4. 因获益和风险尚不明确,所以在急性特发性胰腺炎发作的患者中...
AJG Acquires Two Brokerage Firms.The article reports that Arthur J. Gallagher and Co. has acquired two firms including Park Row Associates Ltd. and IBIS Advisors.EBSCO_bspEmployee Benefit Plan Review
接受托法替布治疗的患者在第90天时需要接受抢救治疗的累积概率低于安慰剂组(0.13 vs 0.38, Log-rank P=0.003)。两组患者的总住院时间没有显著差异。在试验第7天时托法替布组和安慰剂组C反应蛋白中位水平为5.17和6.18mg/L,无显著差异。 安全事件方面,共有20例 (19.2%) 患者,托法替布组13例(24.5%),安慰...
答这句话指的是,如果溶解度 < 1 mg/mL,那我们就认为它是微溶或不溶的,这是针对写的“DMSO:Insoluble”或“DMSO:slightly soluble”这类化合物的。 问细胞实验中需要加多少抑制剂? 答通常建议您参考同模型实验发表的文献报道;除参考文献报道以外,还需要通过预实验做“剂量-效应曲线”确定最佳作用浓度(浓度梯度...
与安慰剂相比,Filgotinib 200 mg 在7天内改善了直肠出血和排便次数 ( P<0.05)。到第 2 周,接受filgotinib 200 mg治疗的患者比接受安慰剂治疗的患者达到 pMCS 缓解的比例更高(未接受过生物治疗的患者,15.1% VS 8.0%,P=0.0410;接受过生物治...